Summary of Significant Accounting Policies (Details) $ / shares in Units, $ in Thousands, R$ in Millions	3 Months Ended		6 Months Ended
	Jul. 01, 2023 USD ($) $ / shares shares	Jul. 02, 2022 USD ($) $ / shares shares	Jul. 01, 2023 USD ($) $ / shares shares	Jul. 02, 2022 USD ($) $ / shares shares	Jul. 01, 2023 BRL (R$)	Dec. 31, 2022 USD ($)	Aug. 01, 2022 USD ($)	Aug. 01, 2022 BRL (R$)	Jan. 01, 2022 USD ($)
Summary of Significant Accounting Policies [Line Items]
Financing Receivable, Sale	$ 130,600	$ 145,000	$ 292,000	$ 271,300
Financing Receivable, Significant Sales, Transaction Fees	1,700	700	3,700	1,100
Basic:
Net income	$ 252,383	$ 201,996	$ 438,184	$ 390,049
Shares (in shares) | shares	159,810,000	161,632,000	159,978,000	161,514,000
Per Share (in usd per share) | $ / shares	$ 1.58	$ 1.25	$ 2.74	$ 2.41
Effect of dilutive securities: [Abstract]
Add: Option shares in the money and dilutive effect of non-vested stock (in shares) | shares	3,308,000	3,781,000	3,363,000	3,879,000
Less: Pro forma treasury shares (in shares) | shares	(748,000)	(668,000)	(748,000)	(720,000)
Diluted:
Net Income	$ 252,383	$ 201,996	$ 438,184	$ 390,049
Shares (in shares) | shares	162,370,000	164,745,000	162,593,000	164,673,000
Per Share (in usd per share) | $ / shares	$ 1.55	$ 1.23	$ 2.69	$ 2.37
Antidilutive Securities [Abstract]
Cash and cash equivalents	$ 111,541		$ 111,541			$ 127,016
Restricted cash	299		299			315
Restricted cash included in other long-term assets	132,279		132,279			22,837
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	244,119	$ 146,840	244,119	$ 146,840		$ 150,168			$ 69,072
FASA Group
Antidilutive Securities [Abstract]
Business Combination, Contingent Consideration, Liability	83,000		$ 83,000		R$ 428.2		$ 168,100	R$ 867.5
FASA Group | Revision of Prior Period, Error Correction, Adjustment
Antidilutive Securities [Abstract]
Business Combination, Contingent Consideration, Liability							$ 85,100
Goodwill, Period Increase (Decrease)	$ 85,144
Stock Options [Member]
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares) | shares	0	0	0	0
Non Vested Stock [Member]
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares) | shares	478,289	249,564	450,248	248,051